SP
Silence Therapeutics Plc
SLN
OTCHealth Care
Income Statement
Total Revenue$43.45M
Gross Profit$31.61M
Operating Income$-63.71M
EBITDA$-41.52M
EBIT$-42.13M
Pre-tax Income$-88.6M
Net Income$-45.28M
Balance Sheet
Net Cash$112.77M
Cash Equivalent$119.24M
Total Debt$216.75K
Net Debt$-112.55M
Book Value$50M
Net Cash Per Share0.80
Book Value Per Share0.38
Key Ratios
Return on Equity (ROE)-264.65%
Return on Assets (ROA)-39.75%
Return on Invested Capital (ROI)-48.53%
Net Profit Margin-231.35%
Current Ratio4.46
Quick Ratioundefined
Long-Term Debt / Equity1.19